Development a translatable visual discrimination test in rodents to apply for drug discovery and development
Project/Area Number |
17H04031
|
Research Category |
Grant-in-Aid for Scientific Research (B)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
General pharmacology
|
Research Institution | Nagoya University |
Principal Investigator |
|
Project Period (FY) |
2017-04-01 – 2020-03-31
|
Project Status |
Completed (Fiscal Year 2019)
|
Budget Amount *help |
¥17,940,000 (Direct Cost: ¥13,800,000、Indirect Cost: ¥4,140,000)
Fiscal Year 2019: ¥5,200,000 (Direct Cost: ¥4,000,000、Indirect Cost: ¥1,200,000)
Fiscal Year 2018: ¥5,200,000 (Direct Cost: ¥4,000,000、Indirect Cost: ¥1,200,000)
Fiscal Year 2017: ¥7,540,000 (Direct Cost: ¥5,800,000、Indirect Cost: ¥1,740,000)
|
Keywords | タッチパネル式視覚弁別試験 / 統合失調症 / 動物モデル / DISC1 / Npas4 / MHC1 / アストロサイト / 注意機能 / Reelin / DREADD / 薬理学 / 神経科学 |
Outline of Final Research Achievements |
Cognitive function in mouse models of schizophrenia was evaluated by a touchscreen-based visual discrimination (VD) test, a rational assay that can be performed by rodents and humans, in order to provide translational validity. Genetic mouse models of schizophrenia, including mouse carrying DISC1 deletion, schizophrenia-associated RELN or ARHGAP10 gene mutation, all exhibited impairments in the VD test, which was accompanied by an increase in c-Fos expression in the prefrontal cortex and dorsomedial striatum. We also demonstrated that mitogen-activated protein kinase signaling in the dopamine D1 receptor expressing-medium spiny neurons of the nucleus accumbens plays an important role in stimulus-reward learning. Through the comprehensive behavioral and neurochemical analyses of genetic mouse models of neuropsychiatric disorders we have identified several new targets for novel drug discovery and development.
|
Academic Significance and Societal Importance of the Research Achievements |
本研究において視覚弁別機能に関連する神経回路の一端が解明できたことにより、高次脳機能の理解が大きく進んだと考えられる。さらに、統合失調症の情動認知機能障害に関わる分子としてDISC1, リーリンおよびARHGAP10を同定した。これらの研究成果は、これまで治療困難であった統合失調症の新規治療薬や予防薬の開発に繋がるものと期待できる。実際、患者型遺伝子変異を有する動物モデルの研究から、ドーパミンD2受容体などの従来の創薬標的とは異なる新しい創薬標的候補分子を同定した。 以上、本研究成果は脳科学研究の発展に寄与するだけでなく、精神疾患の病態解明や新規治療薬の開発への応用展開が可能である。
|
Report
(4 results)
Research Products
(30 results)
-
-
[Journal Article] Generation and analysis of novel Reln-deleted mouse model corresponding to exonic Reln deletion in schizophrenia2020
Author(s)
Masahito Sawahata, Daisuke Mori, Yuko Arioka, Hisako Kubo, Itaru Kushima, Kanako Kitagawa, Akira Sobue, Emiko Shishido, Mariko Sekiguchi, Akiko Kodama, Ryosuke Ikeda, Branko Aleksic, Hiroki Kimura, Kanako Ishizuka, Taku Nagai, Kozo Kaibuchi, Toshitaka Nabeshima, Kiyofumi Yamada, Norio Ozaki
-
Journal Title
Psychiatry and clinical neurosciences
Volume: 1
Issue: 5
Pages: 1-10
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
-
-
-
[Journal Article] Astroglial major histocompatibility complex class I following immune activation leads to behavioral and neuropathological changes.2018
Author(s)
A Sobue, N Ito, T Nagai, W Shan, K Hada, Nakajima A, Y Murakami, A Mouri, Y Yamamoto, T Nabeshima, K Saito, K Yamada
-
Journal Title
Glia
Volume: 66
Issue: 5
Pages: 1034-52
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
[Journal Article] Juvenile social defeat stress exposure persistently impairs social behaviors and neurogenesis.2018
Author(s)
Mouri A, Ukai M, Uchida M, Hasegawa S, Taniguchi M, Ito T, Hida H, Yoshimi A, Yamada K, Kunimoto S, Ozaki N, Nabeshima T, Noda Y.
-
Journal Title
Neuropharmacology.
Volume: 133
Pages: 23-37
DOI
Related Report
Peer Reviewed / Open Access
-
-
-
[Journal Article] Genetic and animal model analyses reveal the pathogenic role of a novel deletion of RELN in schizophrenia.2018
Author(s)
Sobue A, Kushima I, Nagai T, Shan W, Kohno T, Aleksic B, Aoyama Y, Mori D, Arioka Y, Kawano N, Yamamoto M, Hattori M, Nabeshima T, Yamada K, Ozaki N.
-
Journal Title
Sci Rep.
Volume: 8
Issue: 1
Pages: 13046-13046
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
[Journal Article] Innate immune activation of astrocytes impairs neurodevelopment via upregulation of follistatin-like 1 and interferon-induced transmembrane protein 3.2018
Author(s)
Yamada, S., Itoh, N., Nagai, T., Nakai, T., Ibi, D., Nakajima, A., Nabeshima, T., Yamada, K.
-
Journal Title
J. Neuroinflammation.
Volume: 15
Issue: 1
Pages: 295-295
DOI
Related Report
Peer Reviewed / Open Access
-
[Journal Article] Valocin-containing protein (VCP) is a novel IQ motif containing GTPase activating protein 1 (IQGAP1) interacting protein.2017
Author(s)
Itoh, N., Nagai, T,, Watanabe, T., Taki, K., Nabeshima, N., Kaibuchi, K., Yamada, K.
-
Journal Title
Biochem Biophys Res Commun.
Volume: 493
Issue: 4
Pages: 1384-1389
DOI
Related Report
Peer Reviewed / Open Access
-
-
-
-
-
-
-
[Presentation] In vivo imaging for the effect of cocaine.2018
Author(s)
Youyun Zhu,Norimichi ito,Taku Nagai,Keisuke Kuroda,Kozo Kaibuchi,Toshitaka Nabeshima,Kiyofumi Yamada
Organizer
19th Congress of the International Society for Biomedical Research on Alcoholism (ISBRA2018)
Related Report
Int'l Joint Research
-
-
-
-
[Presentation] The pathophusiological role of astroglial MHCI following systemic immune activation2018
Author(s)
Akira Sobue,NorimichiIto,Kazuhiro Hada,Akira Nakajima,Murakami Yuki,Mouri Akihiro,Yamamoto Yasuko,Toshitaka Nabeshima,Kuniaki Saito,Taku Nagai,Kiyofumi Yamada
Organizer
第41回日本神経科学大会
Related Report
-
-
-
-
-
-
-